Cellular Dynamics
WI - MadisonBiotechnology
Focus: Cellular Dynamics is a Wisconsin-based biotechnology company specializing in induced pluripotent stem cell (iPSC) technology for cell therapy applications. The company is publicly traded and focuses on manufacturing and banking of iPS cells derived from whole blood donations.
Profile data last refreshed 12h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Cellular Dynamics
AI assessmentNot HiringNo open roles listed right now. Follow Cellular Dynamics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Cellular Dynamics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Whole Blood Donation
iPS Cell Manufacture and BankingClinical Trials (1)
NCT03434808Generation of an Induced Pluripotent Stem (iPS) Cell Bank Immune Matched to a Majority of the US Population
N/AHelp build intelligence for Cellular Dynamics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.